What Is The Current and Historic Market Size Analysis Of The Single Dose Radiotherapy Services Market?
The single dose radiotherapy services market has seen considerable growth due to a variety of factors.
• The single dose radiotherapy services market is expected to grow from $1.48 billion in 2024 to $1.6 billion in 2025 at a CAGR of 8.5%.
This growth is driven by technological advancements, the integration of big data analytics, the development of portable radiotherapy devices, increased use of robotics, and the adoption of cloud-based treatment planning.
What Is The Forecast For The Single Dose Radiotherapy Services Market Size?
The single dose radiotherapy services market is expected to maintain its strong growth trajectory in upcoming years.
• The single dose radiotherapy services market is projected to grow to $2.19 billion by 2029, at a CAGR of 8.1%.
Growth drivers include rising adoption of single-dose therapies, demand for non-invasive treatments, higher healthcare expenditure, growing elderly population, and expanding telemedicine. Trends include technological advancements, big data analytics integration, portable radiotherapy device development, robotics adoption in radiotherapy, and cloud-based treatment planning.
What Are The Essential Drivers Behind The Growth Of The Single Dose Radiotherapy Services Market?
The surge in cancer instances is expected to fuel the growth of the single-dose radiotherapy services market. Cancer is defined as a group of diseases marked by unchecked cell expansion, often resulting in tumors capable of invading and spreading to other body parts, disrupting regular bodily functions. The rising incidence of cancer is attributed to aging populations, shifts in lifestyle, environmental factors, and improvements in detection and diagnostic procedures. Single-dose radiotherapy services aid in addressing the escalating cancer incidence by offering prompt, efficient treatment aimed at annihilating cancer cells, potentially improving patient outcomes and reducing disease burden. For example, as reported by the International Agency for Research on Cancer (IARC), a France-based intergovernmental organization, in June 2024, the new cases of breast cancer globally surged from 2.26 million in 2020 to 2.31 million in 2022. Hence, the rising cancer incidence is propelling the growth of the single-dose radiotherapy services market.
How Is The Global Single Dose Radiotherapy Services Market Divided Into Key Segments?
The single dose radiotherapy services market covered in this report is segmented –
1) By Type: Internal Beam Radiotherapy, External Beam Radiotherapy
2) By Application: Prostate Cancer, Breast Cancer
3) By Service Provider: Specialized Cancer Institutes, Radiotherapy Centers
Subsegments:
1) By Internal Beam Radiotherapy: Brachytherapy, Intraoperative Radiotherapy (IORT)
2) By External Beam Radiotherapy: Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT), Intensity-Modulated Radiotherapy (IMRT)
Pre-Book The Single Dose Radiotherapy Services Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Single Dose Radiotherapy Services Market?
Prominent enterprises specializing in the single-dose radiotherapy services industry are shifting their attention towards the creation of novel solutions. They are focusing particularly on radiation therapy computed tomography (CT) stations capable of increasing imaging precision and streamlining simulation procedures for cancer care. This new CT solution in radiation therapy is an innovative imaging system that enhances the accuracy of radiation treatment. Meanwhile, the artificially intelligence-boosted version of the intelligent radiation therapy (iRT) platform integrates AI to fine-tune and individualize radiation therapy plans. For example, GE HealthCare, a medical technology firm based in the US, introduced Revolution RT and the enhanced Intelligent Radiation Therapy (IRT) Platform in May 2024. These solutions highlight superior imaging accuracy, efficient workflow, and AI-facilitated customization. Revolution RT is dedicated to precise radiotherapy simulation while the updated iRT platform centralizes processes and increases precision. Such advancements in radiotherapy technology drastically refine imaging precision and accuracy, streamline procedures, and advance personalization and analytical capabilities. This optimizes single-dose radiotherapy treatments for each patient and augments the efficiency, efficacy, and accessibility of these services.
Who Are the Key Players In The Single Dose Radiotherapy Services Market?
Major companies operating in the single dose radiotherapy services market are:
• Hitachi Ltd.
• Varian Medical Systems Inc.
• Boston Scientific Corporation
• Elekta AB
• GenesisCare
• Accuray Incorporated
• IBA Dosimetry GmbH
• Sirtex Medical Limited
• Telix Pharmaceuticals Limited
• ViewRay Inc.
• RaySearch Laboratories AB
• RefleXion Medical Inc.
• Sensus Healthcare Inc.
• C-RAD AB
• Panacea Medical Technologies Pvt. Ltd.
• Advanced Oncotherapy Plc
• ProTom International Inc.
• Isoray Inc.
• IntraOp Medical Corporation
• Alliance Oncology
• Nanobiotix
• Xcision Medical Systems LLC
• Oraya Therapeutics Inc.
What Are The Regional Insights Into The Single Dose Radiotherapy Services Market?
North America was the largest region in the single dose radiotherapy services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single dose radiotherapy services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
